Expressed protein ligation (EPL) allows semisynthesis of a target protein with site-specific incorporation of probes or unnatural amino acids at its N or C termini. Here, we describe the protocol that our lab has developed for incorporating fluorotyrosines (F n Ys) at residue 356 of the small subunit of Escherichia coli ribonucleotide reductase using EPL. In this procedure, the majority of the protein (residues 1-353 out of 375) is fused to an intein domain and prepared by recombinant expression, yielding the protein in a thioester-activated, truncated form. The remainder of the protein, a 22-mer peptide, is prepared by solid-phase peptide synthesis and contains the F n Y at the desired position. Ligation of the 22-mer peptide to the thioester-activated R2 and subsequent purification yield full-length R2 with the F n Y at residue 356. The procedure to generate 100 mg quantities of Y 356 F n Y-R2 takes 3-4 months.
INTRODUCTION

Problem under investigation
The Escherichia coli ribonucleotide reductase (RNR) catalyzes the conversion of all four nucleotides to their corresponding 2¢-deoxynucleotides and consists of two homodimeric subunits: R1 and R2 (refs. 1-3) . R1 is the homodimeric subunit where nucleotide reduction occurs. It contains binding sites for nucleoside diphosphate substrates as well as for deoxynucleoside triphosphate and ATP allosteric effectors, which govern substrate specificity and turnover rates. R2 is the homodimeric subunit, which houses the diiron-tyrosyl radical cofactor (Y 122 ) essential for catalysis. Each turnover requires radical migration from the Y 122 site on R2 to the active site of R1, over a distance of 35 Å . The mechanism of this long-range radical propagation event is an active area of research 4, 5 .
Structures of active RNR, a 1:1 complex of R1 and R2, are not available. However, Uhlin and Eklund 6 have generated a docking model of this complex from the individual structures of R1 and R2 (refs. 7,8) . Their analysis, along with Clustal W alignments of over 160 class I RNR sequences, have suggested a pathway for reversible radical migration, which involves the following residues and perhaps the diiron center: [ (Fig. 1) (refs. 5,6) . Site-directed mutagenesis has been employed to provide evidence that these residues are essential for radical initiation [9] [10] [11] [12] [13] . However, these mutants have not been mechanistically informative, as they exhibit only marginal catalytic activity probably associated to residual wild-type contamination of the purified mutants. Of the 19 natural amino acids that can be substituted for Tyr at this position, only Trp and Cys have oxidation potentials close to that of Tyr, but they are poor structural substitutes 5 . To generate mechanistically more meaningful mutations, we aimed to replace residue Y 356 on the proposed radical initiation pathway in R2 with unnatural amino acids that sterically resemble Tyr and have varying oxidation potentials and pK a s of their phenolic side chains.
To this end, we explored the properties of F n Ys (n ¼ 1-4) and showed that they may serve as probes for disentangling the reactivities of redox-active Tyr residues in proteins ( Fig. 2 ) (see ref. 14) . F n Ys are isosteric with tyrosine, present a range of phenolic pK a s as well as a large range of oxidation potentials ( Table 1) . With the proper choice of F n Y and reaction pH, one can change the protonation state of F n Y 356 , its oxidation potential or both. Thus, F n Ys are excellent probes for examining proton-coupled electron transfer mechanisms in radical propagation and should be generally useful for studying proteins that require stable or transient tyrosyl radicals for catalysis 15, 16 . We next developed an inteinmediated semisynthesis of R2 that allows site-specific replacement of residue Y 356 in R2 with F n Ys 17, 18 . Saccharomyces cerevisiae, was discovered in the early 1990s (ref. 21 ). The potential usefulness of self-splicing in protein engineering fueled detailed studies of the mechanism of action of this multistep process. This understanding led to the development of a number of re-engineered intein constructs that are now commercially available allowing semisynthesis of proteins 22, 23 and consequently sitespecific incorporation of unnatural amino acids. One of these techniques, EPL, is the focus of this protocol.
To demonstrate how EPL works, first the mechanism of intein self-expulsion must be outlined. The proposed mechanism for the S. cerevisiae Vma intein is shown in Figure 3 (see refs. 24, 25) . Splicing is initiated by an N-S acyl shift that converts a peptide bond into a thioester at the N-extein junction site. Transthioesterification via the C-extein Cys residue results in a branched intermediate. This intermediate undergoes excision of the intein domain by attack of an Asn residue on the peptide bond at the C-extein junction site forming an intein succinimide and the spliced extein domains. Spontaneous S-N acyl rearrangement generates the ligated N-and C-exteins connected via an amide bond.
Semisynthesis of R2 using EPL
We have applied EPL to make the R2 subunit of E. coli RNR semisynthetically. R2 is a homodimer with each polypeptide containing 375 amino acids. The C-terminal 35 amino acids of E. coli R2 are disordered and this region houses Y 356 , a residue proposed to be important in the mechanistically unusual radical propagation process described above ( Fig. 1) (ref. 5) . The general scheme that we have used for R2 semisynthesis is shown in Figure 4 (see ref. 17) . Residues 1-353, folded into a native state, are made via recombinant DNA technology and are ligated to residues 354-375, made by solid-phase peptide synthesis (SPPS). The majority of R2 (residues 1-353) is fused to an intein mutant, which lacks the C-extein Asn and Cys residues but contains a purification tag, the chitin-binding domain (CBD) 26 . After recombinant expression, the engineered intein-fusion product catalyzes the first step of the self-cleavage reaction, but not the ensuing splicing steps. The thioester formed is then captured by a small molecule thiol, such as 2-mercaptoethanesulfonic acid (MESNA), via transthiosesterification, resulting in cleavage of the target protein from the intein-CBD construct. The thioester-activated, truncated R2 is then ligated to the remainder of R2, a peptide containing residues 354-375 with the unnatural amino acid at residue 356 and a Cys at its N terminus (residue 354). Transthioesterification of the N-terminal Cys residue of the peptide followed by a spontaneous S-N acyl shift yields full-length R2. Wild-type R2 contains a Ser at 354 and thus a second mutation, in addition to the unnatural amino acid, is introduced into R2 at residue 354. Finally, a third mutation, V 353 G, is required to increase the efficiency of the ligation and consequently the yields to 100 mg quantities of semisynthetic R2 necessary for biophysical experiments.
Advantages and limitations of EPL
A number of methods are in the process of being developed for the incorporation of unnatural amino acids into proteins in a robust fashion 27, 28 . We have chosen EPL for the semisynthesis of R2 for a number of reasons. First, 100 mg quantities of semisynthetic R2, necessary for mechanistic biophysical experiments, are accessible. Second, purification with the CBD tag is robust. Third, residue Y 356 , a member of the radical initiation chain and of great interest to us mechanistically ( Fig. 1) , is at the disordered C-terminal tail of the protein, and therefore a good target for substitution by EPL. Finally, a number of inteins are now commercially available. As shown in Figure 4 , we have used the thiol method to cleave the activated-truncated R2 from the intein-CBD construct, but temperature-and pH-induced cleavage may also be used to generate the desired species. Because of these advantages, the EPL method has been used by numerous investigators, and excellent reviews on its applications are available [29] [30] [31] .
EPL also has a number of limitations. First, site-specific incorporation of probes can only occur close to the N or C termini of the protein because peptides longer than 40-50 residues are difficult to synthesize and purify. Second, the site of ligation must be accessible to solvent in the native protein. If the site of ligation is buried, then the ligation reaction needs to be carried out under denaturing conditions, and methods to refold the protein are required. Third, the thioester-truncated protein undergoes hydrolysis in competition with ligation to the peptide. The rate of ligation, a bimolecular reaction, is elevated by increasing concentrations. However, the The properties listed are for the N-acetyl, C-amide-protected amino acids 14 . a pK a of free tyrosine and F n Y analogues. b pK a of N-acetyl, C-amide-protected tyrosine and F n Y analogues. . It is hoped that other researchers who wish to use EPL to semisynthesize their target protein to incorporate F n Ys will benefit from the detailed procedures described herein and from solutions we have found for the additional problems posed by the multimeric nature of R2, its inability to refold after denaturation and its unstable Y122 under reducing conditions.
Schematic overview of the protocol
The procedure for incorporation of F n Ys into R2 by EPL requires the implementation of three steps that can be regarded as mutually independent sequential protocol blocks: 1. Synthesis and purification of F n Y(s). This block is covered in Steps 1-9 of PROCEDURE.
2. Protection of the amino group of F n Y(s) with the 9-fluorenylmethoxy carbonyl (Fmoc)-protecting group and synthesis and purification of the peptide-22mer (H 2 N-CS(F n Y)LVGQIDSEVD TDDLSNFQL-COOH) containing desired F n Y(s), Steps 10-34.
3. Growth of MESNA-activated, truncated R2 and ligation to the F n Y-22mer(s), Steps 35-50.
MATERIALS
REAGENTS
Note that all purchased chemicals should be of highest available grade from the indicated vendor. It is furthermore common practice to be familiar with the properties and potential hazards of each chemical used-these may be obtained from material safety data sheets (e.g., http://hazard.com/msds).
. Tyrosine phenol lyase (TPL): the expression and purification of TPL from the pTZTPL plasmid has been reported previously [32] [33] [34] . Ammonium acetate (Sigma-Aldrich) . Pyruvic acid (Sigma-Aldrich) . Pyridoxal-5¢-phosphate (PLP) (Sigma-Aldrich) m CRITICAL PLP must be stored dry in the dark at À20 1C.
. n-butanol (Sigma-Aldrich) . Celite 545 (Sigma-Aldrich) . b-Mercaptoethanol (bME) (Mallinckrodt) . Ethyl acetate (Mallinckrodt) ! CAUTION Ethyl acetate is flammable-keep away from sources of ignition.
. Acetic acid (Mallinckrodt) ! CAUTION Acetic acid is corrosive. . Sodium chloride (NaCl) (Mallinckrodt) . HCl solution (B6 N) . Cation exchange resin hydrogen form, AG50W-X8, 50-100 mesh (Bio-Rad) . 10% (v/v) ammonium hydroxide solution . Sodium carbonate (Na 2 CO 3 ) (Sigma-Aldrich) . 9-fluorenylmethyl N-succinimidyl carbonate (Fmoc-OSu) (Sigma-Aldrich) m CRITICAL Fmoc-OSu must be stored dry at À20 1C. . Dichloromethane . Potassium phosphate (KPi) (Mallinckrodt) . Silica gel 60 (particle size 0.04-0.063 mm, 230-400 mesh) (EMD Bioscience)
. O-(7-azabenzotriazole-1-yl)-N,N,N¢,N¢, tetramethyluronium hexafluorophosphate (HATU) (Applied BioSystems) m CRITICAL HATU must be stored dry at o5 1C. A purple/pink spot constitutes a positive result and indicates the presence of a free amine functionality. TPL activity Before synthesis of F n Ys, the activity of the purified TPL should be determined by previously reported methods 32, 33 . One unit of TPL activity (U) is defined as 1 mmol product per min. Purified TPL in our hands has a specific activity of 6-10 U mg À1 . MALDI TOF MS Mass spectra are obtained under negative mode using CHA as the matrix. The matrix is prepared by suspending 10 mg of CHA into a 1 ml solution of 50% (v/v) MeCN and 0.1% (v/v) TFA-1 ml of the peptide (0.5-3 mM) solution is then co-spotted with 1 ml of matrix solution onto the MALDI TOF target and allowed to dry for 0. 4| Before the work-up procedure, the cation exchange resin needs to be prepared. For a 1 liter reaction, use 220 ml of cation exchange resin in a column with dimensions of 4 Â 17 cm. New resin in the protonated form (H + form) may be used after washing with 10 CV of water. After each application, the resin should be cleaned and returned to the protonated form. For this purpose, instructions by the manufacturer should be followed.
5|
After completion of the TPL-mediated formation of F n Y, remove the aluminum foil and lower the pH of the mixture to 2-3 with 6 N HCl. This results in precipitation of TPL.
6| Prepare a celite pad to remove the precipitated TPL: add celite powder to a thickness of 2-3 cm in a 1 liter Buchner funnel (coarse frit) resting on a sidearm suction flask, which is connected to a vacuum line. Rinse the celite pad with B500 ml water, then filter the mixture through the celite pad and collect the filtrate.
7| Extract the filtrate once with 0.5 volumes of ethyl acetate; separate the two layers with a separatory funnel and discard the ethyl acetate layer (top layer). Collect the aqueous layer (bottom layer), which contains the F n Y, in a beaker.
8| Load this mixture onto the cation exchange resin prepared in Step 4 to separate F n Y from residual pyruvic acid, acetic acid and PLP. After loading, wash the column with 8 CV of water.
9|
Elute the F n Y from the column with B8 CV of a 10% ammonium hydroxide solution and collect 10 ml fractions. Pool the fractions that give a positive ninhydrin test (see REAGENT SETUP) and concentrate to 20-30 ml in vacuo using a rotary evaporator with the temperature of the water bath set at 35-40 1C. Lyophilize the remaining solution to dryness and store at 4 1C. Identity of the F n Y is based on the UV properties ( Table 1 ) and its NMR spectrum, which have been reported previously 14 . ' PAUSE POINT F n Ys may be safely stored at 4 1C for several years.
Fmoc protection of F n Y(s) and peptide synthesis of F n Y-22mer(s) TIMING 3 weeks 10| Addition of the Fmoc-protecting group to each F n Y is conveniently carried out on a 0.5-1 mmol scale 35 . Dissolve F n Y (1 mmol) in 3.4 ml of a 10% Na 2 CO 3 solution.
11| Dissolve Fmoc-OSu (1.35 mmol) in 3.5 ml of dioxane in a 100 ml pear-shaped flask fitted with a stir bar. Cool both mixtures to 0-4 1C either by incubating on ice or stirring in a cold room.
12| In one step, add the F n Y solution to the Fmoc-OSu mixture while stirring, then allow the reaction to warm to room temperature. Continue stirring the mixture at room temperature and monitor the reaction progress by TLC (see Table 2 mobile phase and corresponding R f value of each Fmoc-F n Y-OH). The reaction is complete when the intensity of the spot corresponding to Fmoc-F n Y-OH ceases to increase.
13| After completion of the reaction, typically 0.5-2.5 h (higher fluorine substitution requires longer reaction times), add 36 ml of water to the reaction and extract the mixture twice with 15 ml of EtOAc using a separatory funnel to remove unreacted Fmoc-OSu. Discard the EtOAc layer (top layer).
14| Lower the pH of the aqueous phase, which contains Fmoc-F n Y-OH, to 2-3 with 2 N HCl and extract the product into EtOAc (B10Â, 15 ml). Combine the EtOAc extracts.
15| Wash the EtOAc extracts with a saturated NaCl solution (3Â, 4 ml) and water (2Â, 4 ml) and dry over ' PAUSE POINT The product from this procedure may be stored at À20 1C for months.
16| Purify the Fmoc-F n Y-OH by silica gel chromatography (25 g, 1.5 Â 40 cm) using the solvent systems in Table 2 . Purified Fmoc-F n Y-OH can be used directly in peptide synthesis. Note that the hydroxyl group of the fluorophenol does not require protection.
' PAUSE POINT The purified dry Fmoc-F n Y-OH may be stored at À20 1C for up to a year.
17| The first 19 residues (H 2 N-L 19 VGQID 14 S 13 EVDTDDLSNFQL 1 -COOH) of F n Y-22mer are prepared on a peptide synthesizer. Note that residues 13 (Ser) and 14 (Asp) are added as a pseudo-proline dipeptide to avoid peptide aggregation (vide infra) 36 . The remaining three residues, F n Y 20 , S 21 and C 22 , are added manually. In this manner, one can generate multiple F n Y-22mer peptides from the same batch of 19-mer peptide. Should only one of the F n Ys in Figure 2 be of interest, then the entire F n Y-22mer may be prepared on the synthesizer. Because the mode of operation of a peptide synthesizer is brand-and model-specific, the instruction manual for the specific instrument should be followed. Synthesis of the peptide requires two steps that are repeated until the synthesis is complete. The first step is removal of the N-Fmoc-protecting group and the second step is coupling to the next N-Fmoc-protected amino acid in the peptide sequence. Using the synthesizer, the Fmoc group is removed in DMF containing 20% (v/v) piperidine and 0.1 M HOBt (see Fig. 5 and critical step below for the purpose of this reagent) for 10 min with a preset instrument flow rate. The coupling reactions utilized 4 equivalents of Fmoc-protected amino acid, 3.6 equivalents of HATU and 8 equivalents of DIPEA relative to the amount of peptide at final concentrations of 0.5, 0.45 and 1 M, respectively, and proceeded for 1 h. m CRITICAL STEP For the synthesis of the F n Y-22mer peptide, inclusion of HOBt in the deblocking mixture is essential for avoiding aspartimide formation resulting from the reaction sequence shown in Figure 5 . Omitting HOBt during deblocking of the Fmoc group yields peptides that contain a-or b-piperidides. This ''side product'' can constitute as much as 80% of the total peptide when deblocking is performed without HOBt 37 . by breaking up secondary structures 36 . Further, the pseudo-proline moiety is acid-labile and yields the desired S 13 and D 14 residues after TFA-mediated cleavage of the peptide from the solid-phase resin (vide infra). ' PAUSE POINT At the end of the automated synthesis of the 19-mer peptide, the resin-bound, Fmoc-protected peptide may be stored dry at À80 1C for a year.
18|
The next three residues may now be coupled manually. Transfer the resin-bound peptide into a capped Econo-pac column. These columns are capped at the top and bottom during the reaction. Remove the Fmoc group from the N-terminal end of the resin-bound nascent peptide by shaking it in the Econo-pac column on a vortexer with a deblocking mixture consisting of 20% (v/v) piperidine and 0.1 M HOBt in DMF for 10-12 min. Remove the bottom and top caps to drain the deblocking mixture. Add fresh deblocking mixture and vortex for another 10-12 min. Drain the deblocking solution as before. Use 15 ml of deblocking solution per gram of resin.
19| After deblocking, wash the resin 4-5 times with DMF by adding 7-8 ml of DMF per gram of resin, vortexing for B1 min and draining the DMF from the column by removing the top and bottom caps. After the last wash, blow N 2 gas through the column to remove residual DMF completely. 22| Add the N-terminal Cys residue in its pentafluorophenol-activated and t Buthio-protected form. Coupling of this residue requires vortexing with 6 equivalents of Fmoc-Cys( t Buthio)-OPfp and 6 equivalents of HOBt relative to peptide at final concentrations of 0.5 M each for 1.5 h. Wash the resin 2-3 times with DMF as described in Step 19 and deblock the Fmoc-protecting group as described in Steps 18 and 19. m CRITICAL STEP Cys residues have a propensity to racemize when coupled using DIPEA 38 . To avoid Cys racemization, the N-terminal Cys residue is coupled as an activated OPfp ester obviating the need for a base.
23| Before cleavage of the peptide from the resin, wash the resin-bound peptide 2-3 times with CH 2 Cl 2 as described in Step 19 for DMF washes. Then, cap the Econo-Pac column at the top, but not at the bottom, and connect the bottom of the column to a vacuum line. Pull a vacuum for 5-10 min to dry the resin completely.
24| Cleave the peptide from the resin by shaking the resin with a solution consisting of 95% TFA, 2.5% TIS and 2.5% water for 4 h. Use 25 ml of cleavage solution per gram of resin.
25| After 4 h, the TFA solution will contain the free peptide. Drain this solution into a 50 ml Falcon tube and wash the resin 2-3 times with a small volume of TFA. Combine the TFA washes with the cleavage solution. Table 1) . Collect the fractions containing the peptide, remove MeCN in vacuo by rotary evaporation (water bath temperature set at 25 1C) and lyophilize the remaining peptide solution to dryness.
30|
The purity of the peptide is assessed using analytical HPLC. A linear gradient of 10-75% MeCN over 45 min versus 0.1 M NH 4 HCO 3 (pH 8.0) is used to elute the peptide from the Jupiter Phenomenex column. A typical profile is shown in Figure 6 .
31| Obtain a UV spectrum and MALDI-TOF MS on each purified peptide to ascertain its identity. Table 1 summarizes the absorption maxima and extinction coefficients of C-and N-terminally blocked F n Ys in the phenol and phenolate forms. As there are no other Trp or Tyr residues in the peptide sequence, the F n Ys are predominantly responsible for the absorbance in the B270 nm region.
32| Finally, the t Buthio-protecting group on the N-terminal Cys residue must be removed. To avoid intermolecular disulfide bond formation between two peptides, removal of the t Buthio group is performed under anaerobic conditions. Disulfide formation is more prevalent from the thiolate form of the Cys residue, predominantly present as the peptide is soluble only under mildly basic conditions. Suspend the lyophilized peptide in 0.1 M NH 4 HCO 3 (aq.) (pH 8.0) to a final concentration of 1-7 mM and add 0.1 volume of 250 mM Tris (pH 8.0). For example, to deprotect 5 mmol of peptide, suspend it in a 3 ml solution of 0.1 M NH 4 HCO 3 (pH 8.0) and add 300 ml of 250 mM Tris (pH 8.0). Transfer the solution to a pear-shaped flask and deoxygenate it on a Schlenk line by alternating cycles of degassing, by pulling a vacuum, followed by readdition of argon gas. Six to eight cycles are required for complete degassing. In each cycle, the flask is degassed by pulling a vacuum for B2-5 min and then flushed with argon with stirring for B5 min.
33|
Add solid DTT to a 15-fold molar excess over peptide. During this addition, the mixture is briefly exposed to atmosphere. Therefore, degas the mixture again as described in Step 32. Stir the reaction mixture at room temperature for 4 h.
34| After 4 h, transfer the reaction mixture to a dialysis bag and dialyze anaerobically (as described in EQUIPMENT SETUP) against 5 mM potassium phosphate, pH 6.0 (1 liter, 2-3 changes of 4 h each). After dialysis, transfer the peptide solution to a Falcon tube, freeze and lyophilize to dryness. ' PAUSE POINT The purified, dry peptide may be stored at À80 1C for a year.
Ligation of F n Y-22mer(s) to MESNA-activated R2 TIMING 3-4 weeks 35| Transform pR2-intein-CBD 17 into BL21-DE3 codon+ cells using instructions provided by the manufacturer. m CRITICAL STEP For the semisynthesis of R2, the Stratagene codon+ competent cell line yielded optimal expression, purification and radical content. Note that depending on the origin of the intein, codon+ cell lines may not be necessary. To determine whether codon+ cell lines are required, the codon usage of the organism from which the intein originates should be compared to that of E. coli or the organism in which expression is performed.
36| Carry out small and large culture growths with shaking (200 r.p.m.) at 37 1C in LB containing Amp (100 mg ml À1 ) and Cm (50 mg ml À1 ). Inoculate a 5 ml LB/Amp/Cm culture (in a 12 ml bacterial culture tube) with a single colony obtained from the transformation in Step 35. ' PAUSE POINT Grow cells to saturation overnight (B12 h). 37| Dilute 0.5 ml of the saturated small culture into a 100 ml medium culture of LB/Amp/Cm in a 500 ml Erlenmeyer flask. ' PAUSE POINT Grow this medium culture to saturation overnight (B12 h).
38| Finally, inoculate a 10-liter LB/Amp/Cm large culture (5 Â 2-liter cultures in 6-liter Erlenmeyer flasks) with 50 ml of the saturated medium culture, and continue growth at 37 1C. m CRITICAL STEP The R2-intein-CBD chimera is insoluble at 37 1C; therefore, expression must be performed at 23 1C. Also, the thioester linkage in the expressed truncated R2 is unstable even at À80 1C. Therefore, for optimal ligation yields, purification of the truncated R2 construct must be performed within a few days of growth. 41| Collect the supernatant and load it onto the pre-equilibrated chitin column (see EQUIPMENT SETUP) at a flow rate of B1-3 ml min À1 . A total of 5 ml of chitin resin is required per gram of cell paste. 43| After 30 h, elute the MESNA-activated R2 from the chitin column with cleavage buffer. The amount of protein is monitored using the Bradford reagent assay (see manufacturer's instructions). Continue elution until no more protein is detected. m CRITICAL STEP The amount of MESNA-activated R2 eluting from the column is dependent on the concentration of MESNA and the period of incubation as described above. It is also dependent on the C-terminal residue of truncated R2 containing the MESNA thioester (residue 353, which is a valine in wild-type R2, but a glycine in all of our R2-intein-CBD constructs). Bulky side chains at this position sterically hinder access of the small molecule thiol to the thioester. We have determined cleavage efficiencies of 50%, 15% and 10%, when residue 353 is Gly, Ala and Val, respectively. Because we required 100 mg quantities of semisynthetic R2 for biophysical experiments that we wished to carry out, all our R2 semisyntheses were performed with Gly at residue 353. The cleavage efficiency is also dependent on the small molecule thiol. Ideally, the thiol is a good nucleophile for optimal cleavage and a good leaving group for optimal ligation (vide infra). We found MESNA to yield the best combined cleavage and ligation efficiencies. Although DTT yielded the highest cleavage efficiency, ligation yields were poor. Other thiols tested were bME, ethanethiol, thiophenol and benzylmercaptan. Although thiophenol is not expected to be a good cleavage reagent, its use for this purpose has been reported 39 .
42|
44| After elution, concentrate the MESNA-activated R2 to 20-25 mg ml À1 using an Amicon concentration device with a YM-30 membrane. Then, remove the excess MESNA from the MESNA-activated R2 using Sephadex G-25 chromatography in cleavage buffer. Because this desalting step results in protein dilution, concentrate the MESNA-activated R2 again to 20-25 mg ml À1 using a YM-30 Centriprep protein concentrator.
45| Degas the protein on a Schlenk line with ten cycles of vacuum degassing for 5-10 s followed by argon fill for 1 min with stirring. Transfer the protein sample into the glove box for the ligation step. Transfer the lyophilized peptide to the glove box as well.
46| Set up the ligation reaction by adding peptide to a final concentration of 2 mM to the degassed, truncated, MESNA-activated R2. Then add 0.1 volumes of 1.5 M HEPES and 0.4 mM EDTA (pH 7.9). Typically, the ligation reaction contains, in a final volume of 3 ml, 20 mg ml À1 MESNA-activated R2 (0.7 mmol) and 2 mM peptide (6 mmol). ' PAUSE POINT Incubate the reaction mixture at 4 1C in the glove box for 36 h. m CRITICAL STEP Note that stirring is not recommended as it induces protein precipitation under these conditions. Instead, gently swirl the flask 3-4 times during the incubation period. m CRITICAL STEP As described in Step 43, the small molecule thiol of choice is one that yields high cleavage and ligation efficiencies. Previously, Kent and co-workers 40 reported the use of small molecule thiol catalysts for the ligation reaction. We tested the ability of thiophenol and p-nitrothiophenol to function in this capacity using the truncated, MESNA-activated R2. However, we observed no improvement in the ligation yield.
47| Divide the B3 ml ligation mixture into 1 ml aliquots in 1.5 ml Eppendorf tubes, flash-freeze in liquid N 2 and store at À80 1C.
' PAUSE POINT The ligation mixture is stable at À80 1C for a year. m CRITICAL STEP The removal of the adventitiously bound peptide is critical for experiments performed with R2, as the C-terminal peptide provides the key binding sites for interaction with R1. Note that depending on the peptide sequence, it may not be removed by concentration-dilution cycles through a membrane-this possibility needs to be investigated for the peptide of interest (e.g., by non-reducing SDS-PAGE). Should removal not occur by concentration-dilution cycles, then Sephadex G-25 chromatography under reducing conditions may be used to remove the peptide. Furthermore, the ensuing purification on a MonoQ column (Step 49) is carried out under reducing conditions to ensure complete removal of adventitiously bound peptide.
49| Inject 10-20 mg of the ligation reaction onto a MonoQ anion exchange column (2 ml injection loop). Elute R2 with a linear NaCl gradient-a typical elution profile is shown in Figure 7 . Because of the negative charge associated with the C-terminal 22 amino acids of R2, the heterodimer can be separated from the two homodimers. Pool the desired fractions (corresponding to peaks 2 and 3 in Fig. 7 ), concentrate to B150 mM and store at À80 1C. Typically, 10 g of wet cell paste yielded 50 mg of truncated MESNA-activated R2, which after ligation yielded 15-20 mg of full-length R2. ' PAUSE POINT F n Y-R2 may be safely stored at À80 1C for several years. ? TROUBLESHOOTING Troubleshooting advice can be found in Table 3 . 
